Poland· PL-100254045

Adadox

A doxazosin product containing doxazosinum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 13 of our 19 countries.

ATC C02CA04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAdadoxATCC02CA04REGISTER NO.PL-100254045PACKS LISTED14CHECKEDSeptember 27, 2026

Where it is registered

Doxazosin is registered in 13 of 19 countries.

Countries holding a registration under ATC C02CA04 (doxazosin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Doxazosin · ATC C02CA04

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of doxazosin costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.35 in Italy to $0.59 in Switzerland — a ×1.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Doxazosin · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.59
  • IT Italy$0.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Doxazosinum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
C02CA04
ATC class
Doxazosin
Defined daily dose
4 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 14

1 priced
  • gtin
    05909990901845
  • gtin
    05909990901852
  • gtin
    05909990901890
    30 szt.
    PLN 9.11
  • gtin
    05909990901975
  • gtin
    05909990901982
  • gtin
    05909990901869
  • gtin
    05909990901876
  • gtin
    05909990901883
  • gtin
    05909990901906
  • gtin
    05909990901920
  • gtin
    05909990901937
  • gtin
    05909990901944
  • gtin
    05909990901951
  • gtin
    05909990901968

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

259 interactions on record for doxazosin.

Graded by severity as the source publishes them — 85 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxazosin · interactions on record

259 records

  • 85 moderate
  • 173 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxazosin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxazosin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Ascalan, Doxazosin 1a Pharma
  • Bulgaria · Доксазосин Чайкафарма, Зоксон
  • Cyprus · Cardura, Magurol
  • Czechia · Doxazosin G.L. Pharma, Kamiren
  • Germany · Cardular, Cardular Pp
  • Denmark · Cardosin Retard, Carduran Retard
  • Estonia · Cardura, Cardura Xl
  • Spain · Carduran Neo, Doxazosina Alter
  • France · Doxazosine L.P. Viatris, Doxazosine Lp Arrow
  • United Kingdom (Northern Ireland) · Cardura, Cardura Xl
  • Greece · Cardura, Maguran
  • Croatia · Doxa, Doxazin
  • Hungary · Cardura, Cardura Xl
  • Ireland · Cardura, Cardura Xl
  • Iceland · Cardosin Retard, Carduran Retard
  • Italy · Benur, Cardura
  • Lithuania · Cardura, Cardura Xl
  • Latvia · Cardura, Cardura Xl
  • Malta · Cardura, Doxatan
  • Netherlands · Cardura Xl, Doxazosin Syri Pharma
  • Norway · Carduran Cr
  • Portugal · Cardura Gits, Doxazosina Generis
  • Romania · Cardura Xl, Doxazosin Arena
  • Sweden · Alfadil, Alfadil Bph
  • Slovenia · Cardura Xl, Kamiren
  • Slovakia · Kamiren Xl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5b01b6c-4c0b-4e9b-82ff-1be45a60ca5c
GET /v1/drugs/b5b01b6c-4c0b-4e9b-82ff-1be45a60ca5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909990901845 ¦ Rp ¦ 69286\n10 tabl.\n05909990901852 ¦ Rp ¦ 69287\n14 tabl.\n05909990901869 ¦ Rp ¦ 69288\n15 tabl.\n05909990901876 ¦ Rp ¦ 69289\n20 tabl.\n05909990901883 ¦ Rp ¦ 69290\n28 tabl.\n05909990901890 ¦ Rp ¦ 69291\n30 tabl.\n05909990901906 ¦ Rp ¦ 69292\n50 tabl.\n05909990901920 ¦ Rp ¦ 69293\n56 tabl.\n05909990901937 ¦ Rp ¦ 69294\n60 tabl.\n05909990901944 ¦ Rp ¦ 69295\n90 tabl.\n05909990901951 ¦ Rp ¦ 69296\n98 tabl.\n05909990901968 ¦ Rp ¦ 69297\n100 tabl. w blistrze\n05909990901975 ¦ Rp ¦ 69298\n140 tabl.\n05909990901982 ¦ Rp ¦ 69299\n100 tabl. w pojemniku",
  "substance": "Doxazosini mesilas 2.42 mg",
  "common_name": "Doxazosinum",
  "pl_product_id": "100254045",
  "pozwolenie_nr": "18844",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about doxazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.